Alex Kudrin
Impact in
- Immunology top 10%
- Biosimilars and Bioanalytical Methods
- Macrophage Migration Inhibitory Factor
- Immunotherapy and Immune Responses
-
- CAR-T cell therapy research
Papers in
- Immunology 11
- Biosimilars and Bioanalytical Methods 5
- Immunotherapy and Immune Responses 4
-
- Health Systems, Economic Evaluations, Quality of Life 3
- Pharmaceutical Economics and Policy 3
- Co-authors
- Jürgen Braun (2 shared papers)David Ray (2 shared papers)Michael G. Hanna (1 shared paper)B L Hazleman (1 shared paper)Andrew J.K. Östör (1 shared paper)Meryl Griffiths (1 shared paper)Edwin R. Chilvers (1 shared paper)Keith P. Ray (1 shared paper)
- Journals
- Human Vaccines & Immunotherapeutics (6 papers)Biologicals (2 papers)Journal of Biological Chemistry (1 paper)Immunology and Cell Biology (1 paper)The Journal of Clinical Pharmacology (1 paper)
- Partner nations
- South KoreaNew ZealandUnited Kingdom
In The Last Decade
Alex Kudrin
14 papers receiving 304 citations
Peers
Comparison fields: 5 of 53
- Immunology 204
- Oncology 50
- Rheumatology 23
- Physiology 39
- Economics and Econometrics 40
Countries citing papers authored by Alex Kudrin
This map shows the geographic impact of Alex Kudrin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alex Kudrin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alex Kudrin more than expected).
Fields of papers citing papers by Alex Kudrin
This network shows the impact of papers produced by Alex Kudrin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alex Kudrin. The network helps show where Alex Kudrin may publish in the future.
Co-authors
The 17 scholars most cited alongside Alex Kudrin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 66 | |
| 2 | 2007 | 47 | |
| 3 | Sarcoid-like granulomatous disease following etanercept treatment for RA. | 2007 | 47 |
| 4 | 2006 | 45 | |
| 5 | 2012 | 18 | |
| 6 | 2012 | 15 | |
| 7 | 2015 | 15 | |
| 8 | 2014 | 14 | |
| 9 | 2012 | 11 | |
| 10 | 2014 | 10 | |
| 11 | 2009 | 9 | |
| 12 | 2013 | 8 | |
| 13 | 2012 | 4 | |
| 14 | 2012 | 2 |
About Alex Kudrin
Alex Kudrin is a scholar working on Immunology, Economics and Econometrics, Oncology, Molecular Biology and Pediatrics, Perinatology and Child Health, having authored 14 papers that have together received 311 indexed citations. Recurring topics across this work include Biosimilars and Bioanalytical Methods (5 papers), Immunotherapy and Immune Responses (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers), Pharmaceutical Economics and Policy (3 papers), vaccines and immunoinformatics approaches (3 papers), Pharmaceutical studies and practices (3 papers) and Rheumatoid Arthritis Research and Therapies (2 papers). The work is most often cited by research in Immunology (204 citations), Oncology (50 citations), Rheumatology (23 citations), Physiology (39 citations) and Economics and Econometrics (40 citations). Alex Kudrin has collaborated with scholars based in South Korea, New Zealand and United Kingdom. Frequent co-authors include Jürgen Braun, David Ray, Michael G. Hanna, B L Hazleman, Andrew J.K. Östör, Meryl Griffiths, Edwin R. Chilvers, Keith P. Ray, Steven M. Martin and Martin Scott. Their work appears in journals such as Human Vaccines & Immunotherapeutics, Biologicals, Journal of Biological Chemistry, Immunology and Cell Biology and The Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.